Video

Barry Singer, MD

Publish date: October 19, 2015

At ECTRIMS 2015 in Barcelona, Dr. Singer discussed the initial data set from vsMS, a global survey of patients with MS and their caregivers. The survey was aimed at raising awareness of the emotional and physical burden of relapsing-remitting MS.

 

References

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

Recommended Reading

Stacey Cofield, PhD, of NARCOMS
MDedge Neurology
Long-Term Efficacy of Fingolimod Reinforced by New NEDA-4 Analysis
MDedge Neurology
Minocycline for MS?
MDedge Neurology
Daclizumab Reduces Brain Volume Loss, Compared With Interferon
MDedge Neurology
Cannabinoid Spray Effectively Relieves MS-Related Spasticity
MDedge Neurology
Anti-JCV Antibody Index and L-Selectin Hone PML Risk Stratification During Natalizumab Therapy
MDedge Neurology
Sodium Channel Blockade With Phenytoin Has a Neuroprotective Effect After Acute Optic Neuritis
MDedge Neurology
Daclizumab’s efficacy against MS tempered by adverse events
MDedge Neurology
Ocrelizumab posts first-ever positive outcome data for primary progressive MS
MDedge Neurology
Ocrelizumab decreases relapses, brain lesion development in relapsing-remitting MS
MDedge Neurology

Related Articles